SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by K.J. Harrison & Partners Inc

K.J. Harrison & Partners Inc grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 23,800 shares of the exchange traded fund’s stock after purchasing an additional 2,000 shares during the period. K.J. Harrison & Partners Inc’s holdings in SPDR S&P Biotech ETF were worth $2,178,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Healthcare of Ontario Pension Plan Trust Fund raised its position in SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after buying an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $141,284,000. Assetmark Inc. grew its stake in shares of SPDR S&P Biotech ETF by 72,653.0% in the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after buying an additional 588,489 shares in the last quarter. Mirae Asset Securities USA Inc. increased its holdings in SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after buying an additional 300,000 shares during the last quarter. Finally, Sivik Global Healthcare LLC bought a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $29,640,000.

SPDR S&P Biotech ETF Stock Down 0.5 %

XBI stock opened at $88.25 on Thursday. The company has a market capitalization of $5.82 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The firm has a 50 day moving average of $91.11 and a two-hundred day moving average of $95.87. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.